PL204215B1 - Pochodne fenylosulfonyloetylopiperydyny, środek leczniczy, sposób wytwarzania pochodnych fenylosulfonyloetylopiperydyny i ich zastosowanie - Google Patents
Pochodne fenylosulfonyloetylopiperydyny, środek leczniczy, sposób wytwarzania pochodnych fenylosulfonyloetylopiperydyny i ich zastosowanieInfo
- Publication number
- PL204215B1 PL204215B1 PL361387A PL36138701A PL204215B1 PL 204215 B1 PL204215 B1 PL 204215B1 PL 361387 A PL361387 A PL 361387A PL 36138701 A PL36138701 A PL 36138701A PL 204215 B1 PL204215 B1 PL 204215B1
- Authority
- PL
- Poland
- Prior art keywords
- compound
- hydroxypiperidin
- ethanesulfonyl
- benzyl
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00117918 | 2000-08-21 | ||
| PCT/EP2001/009561 WO2002016321A1 (en) | 2000-08-21 | 2001-08-20 | Prodrugs to nmda receptor ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL361387A1 PL361387A1 (en) | 2004-10-04 |
| PL204215B1 true PL204215B1 (pl) | 2009-12-31 |
Family
ID=8169594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL361387A PL204215B1 (pl) | 2000-08-21 | 2001-08-20 | Pochodne fenylosulfonyloetylopiperydyny, środek leczniczy, sposób wytwarzania pochodnych fenylosulfonyloetylopiperydyny i ich zastosowanie |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US6407235B1 (https=) |
| EP (1) | EP1313703B1 (https=) |
| JP (1) | JP4162991B2 (https=) |
| KR (1) | KR100589991B1 (https=) |
| CN (1) | CN1227230C (https=) |
| AR (1) | AR030373A1 (https=) |
| AT (1) | ATE386022T1 (https=) |
| AU (2) | AU8589401A (https=) |
| BR (1) | BR0113348A (https=) |
| CA (1) | CA2419279C (https=) |
| CY (1) | CY1107937T1 (https=) |
| CZ (1) | CZ303319B6 (https=) |
| DE (1) | DE60132782T2 (https=) |
| DK (1) | DK1313703T3 (https=) |
| EC (1) | ECSP034489A (https=) |
| EG (1) | EG24293A (https=) |
| ES (1) | ES2299508T3 (https=) |
| HR (1) | HRP20030125B1 (https=) |
| HU (1) | HU229802B1 (https=) |
| IL (1) | IL154254A0 (https=) |
| JO (1) | JO2289B1 (https=) |
| MA (1) | MA26947A1 (https=) |
| MX (1) | MXPA03001311A (https=) |
| MY (1) | MY136065A (https=) |
| NO (1) | NO324941B1 (https=) |
| NZ (1) | NZ523990A (https=) |
| PA (1) | PA8525601A1 (https=) |
| PE (1) | PE20020291A1 (https=) |
| PL (1) | PL204215B1 (https=) |
| PT (1) | PT1313703E (https=) |
| RS (1) | RS51467B (https=) |
| RU (1) | RU2272027C2 (https=) |
| SI (1) | SI1313703T1 (https=) |
| WO (1) | WO2002016321A1 (https=) |
| ZA (1) | ZA200300894B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1265864A1 (en) * | 2000-03-21 | 2002-12-18 | The Procter & Gamble Company | Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| US6713490B2 (en) | 2002-04-26 | 2004-03-30 | Pfizer, Inc. | 3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists |
| CA2633010A1 (en) * | 2005-12-19 | 2007-06-28 | Methylgene Inc. | Histone deacetylase inhibitors for enhancing activity of antifungal agents |
| US8796330B2 (en) * | 2006-12-19 | 2014-08-05 | Methylgene Inc. | Inhibitors of histone deacetylase and prodrugs thereof |
| EP1973872A4 (en) | 2006-12-19 | 2012-05-09 | Methylgene Inc | HISTONDEACETYLASE HEMMER AND PROPHARMAKA THEREOF |
| PL4001272T3 (pl) | 2013-11-05 | 2025-02-10 | Astrazeneca Ab | Proleki antagonisty nmda |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1048247C (zh) * | 1994-01-31 | 2000-01-12 | 美国辉瑞有限公司 | 神经保护的苯并二氢吡喃化合物 |
| DE4410822A1 (de) | 1994-03-24 | 1995-09-28 | Schering Ag | Neue Piperidin-Derivate |
| TW340842B (en) * | 1995-08-24 | 1998-09-21 | Pfizer | Substituted benzylaminopiperidine compounds |
| TW498067B (en) | 1996-07-19 | 2002-08-11 | Hoffmann La Roche | 4-hydroxy-piperidine derivatives |
| TWI254043B (en) | 1999-06-08 | 2006-05-01 | Hoffmann La Roche | Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor |
-
2001
- 2001-08-16 PE PE2001000820A patent/PE20020291A1/es not_active Application Discontinuation
- 2001-08-16 PA PA20018525601A patent/PA8525601A1/es unknown
- 2001-08-16 US US09/931,431 patent/US6407235B1/en not_active Expired - Lifetime
- 2001-08-17 MY MYPI20013876A patent/MY136065A/en unknown
- 2001-08-17 AR ARP010103939A patent/AR030373A1/es active IP Right Grant
- 2001-08-19 JO JO2001136A patent/JO2289B1/en active
- 2001-08-20 ES ES01965201T patent/ES2299508T3/es not_active Expired - Lifetime
- 2001-08-20 AU AU8589401A patent/AU8589401A/xx active Pending
- 2001-08-20 RS YUP-130/03A patent/RS51467B/sr unknown
- 2001-08-20 EG EG20010906A patent/EG24293A/xx active
- 2001-08-20 DK DK01965201T patent/DK1313703T3/da active
- 2001-08-20 RU RU2003107572/04A patent/RU2272027C2/ru not_active IP Right Cessation
- 2001-08-20 MX MXPA03001311A patent/MXPA03001311A/es active IP Right Grant
- 2001-08-20 JP JP2002521197A patent/JP4162991B2/ja not_active Expired - Fee Related
- 2001-08-20 CN CNB01814361XA patent/CN1227230C/zh not_active Expired - Fee Related
- 2001-08-20 PT PT01965201T patent/PT1313703E/pt unknown
- 2001-08-20 CA CA002419279A patent/CA2419279C/en not_active Expired - Fee Related
- 2001-08-20 HU HU0301548A patent/HU229802B1/hu not_active IP Right Cessation
- 2001-08-20 EP EP01965201A patent/EP1313703B1/en not_active Expired - Lifetime
- 2001-08-20 CZ CZ20030492A patent/CZ303319B6/cs not_active IP Right Cessation
- 2001-08-20 NZ NZ523990A patent/NZ523990A/en not_active IP Right Cessation
- 2001-08-20 SI SI200130812T patent/SI1313703T1/sl unknown
- 2001-08-20 HR HR20030125A patent/HRP20030125B1/xx not_active IP Right Cessation
- 2001-08-20 AU AU2001285894A patent/AU2001285894B2/en not_active Ceased
- 2001-08-20 AT AT01965201T patent/ATE386022T1/de active
- 2001-08-20 IL IL15425401A patent/IL154254A0/xx not_active IP Right Cessation
- 2001-08-20 BR BR0113348-9A patent/BR0113348A/pt not_active Application Discontinuation
- 2001-08-20 PL PL361387A patent/PL204215B1/pl unknown
- 2001-08-20 DE DE60132782T patent/DE60132782T2/de not_active Expired - Lifetime
- 2001-08-20 KR KR1020037002485A patent/KR100589991B1/ko not_active Expired - Fee Related
- 2001-08-20 WO PCT/EP2001/009561 patent/WO2002016321A1/en not_active Ceased
-
2003
- 2003-01-31 ZA ZA200300894A patent/ZA200300894B/en unknown
- 2003-02-19 NO NO20030781A patent/NO324941B1/no not_active IP Right Cessation
- 2003-02-20 EC EC2003004489A patent/ECSP034489A/es unknown
- 2003-02-21 MA MA27052A patent/MA26947A1/fr unknown
-
2008
- 2008-05-08 CY CY20081100485T patent/CY1107937T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0383579B1 (en) | N-Phenyl-N-(4-piperidinyl)amides useful as analgesics | |
| Feldman et al. | Design, synthesis, and pharmacological evaluation of ultrashort-to long-acting opioid analgesics | |
| DE60129210T2 (de) | Zyklische amid-derivate | |
| DE69518194T2 (de) | Hydroxamsäure-Derivate mit drei Ringsubstituenten | |
| BG107460A (bg) | Производни на бензимидазола, тяхното получаване иприложението им в терапията | |
| EP0319429A2 (en) | 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient | |
| JPH11509541A (ja) | 新規なガランタミン誘導体、その製造方法、その医薬としての用途及びそれを含有する医薬組成物 | |
| PL204215B1 (pl) | Pochodne fenylosulfonyloetylopiperydyny, środek leczniczy, sposób wytwarzania pochodnych fenylosulfonyloetylopiperydyny i ich zastosowanie | |
| AU2001285894A1 (en) | Prodrugs to NMDA receptor ligands | |
| EP1097924A1 (en) | 4-hydroxy-4-phenylpiperidine derivatives having -opioid agonist activity and pharmaceuticals containing the same | |
| EP0389425B1 (de) | Neue Benzothiopyranylamine | |
| US5362736A (en) | Isoquinoline derivatives | |
| AU2014240139A1 (en) | Muscarinic agonists | |
| EP0663395A1 (de) | 3-(Phenylalkylaminoalkyloxy)-5-phenylpyrazol-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihrer Verwendung als herzfrequenzsenkendes Mittel | |
| WO1995025100A1 (fr) | Utilisation d'esters de l'acide 4-amino-5-chloro-2-methoxybenzoique comme 5-ht4 agonistes | |
| TWI306453B (en) | Prodrugs to nmda receptor ligands, process for preparing the same and medicament comprising the same | |
| EP0508004A1 (en) | Phenylsulfonylalkanoic acid compounds | |
| JPS6022711B2 (ja) | トランス−デカハイドロキノリン誘導体，その製造法，及びそれを含む医薬 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RECP | Rectifications of patent specification |